Latest Advances in Lung Cancer Research

Final study results show selpercatinib achieves 83% response rate in treatment-naive RET fusion lung cancer patients with durable responses.

Increasing lung cancer cases in non-smokers highlight the need for research into causes and improved detection methods

UC Davis Health introduces cutting-edge CT imaging technology that detects smaller lung tumors with less radiation, improving early detection and treatment planning.

Obesity paradox in lung cancer: Study finds obesity associated with improved survival in NSCLC patients, particularly those with preserved skeletal muscle quality and quantity.

New study reveals higher lung cancer incidence in women under 65 than in men, with rates increasing among younger women despite declining smoking trends.

Expanding lung cancer screening to those aged 50-80 with 20 pack-year smoking history could increase eligibility by 87%, reducing disparities and saving lives.

Lung cancer mortality trends show significant disparities by sex, age, and ethnicity, with declining rates overall but persistent gaps in healthcare access and outcomes.

New study reveals genetic factors protect some lifelong smokers from lung cancer, identifying robust mechanisms that limit mutation accumulation and improve early detection strategies

The Veterans Health Administration promotes lung cancer screening with low-dose CT scans for eligible veterans aged 50-80 with a 20+ pack-year smoking history.

The Lung Cancer Genetics Study aims to understand genetic factors in lung cancer, improving detection, risk reduction, and care through a collaborative research effort.

Wildfire smoke exposure increases lung cancer risk and worsens patient outcomes, particularly for vulnerable populations and those recovering from lung cancer surgery.

RYBREVANT and LAZCLUZE combination shows significant overall survival benefit in EGFR-mutated NSCLC patients, exceeding one year median survival improvement over standard osimertinib treatment.